The Use of Urea in the Treatment of Dry Skin

Chapter

Abstract

Moisturizers have different effects on the skin structure and function. Moisturizers that reduce the signs of dryness and strengthen skin barrier function are believed to also reduce the prevalence of inflammatory dermatosis.

The naturally occurring humectant urea has been reported to both enhance and retard the penetration. In the majority, but not all clinical and experimental studies on urea, improvement of dryness and skin barrier function has been noted. A moisturizer with urea has also been shown to delay relapse of eczema in atopic patients and in patients with hand eczema. The treatment has been found cost-effective compared with no treatment in adult patients with atopic dermatitis in the four Nordic countries.

Keywords

Atopic Dermatitis Stratum Corneum Hand Eczema Atopic Patient Skin Barrier Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Palmer CN et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446PubMedCrossRefGoogle Scholar
  2. 2.
    Weidinger S et al (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118(1):214–219PubMedCrossRefGoogle Scholar
  3. 3.
    Rawlings AV, Harding CR (2004) Moisturization and skin barrier function. Dermatol Ther 17(Suppl 1):43–48PubMedCrossRefGoogle Scholar
  4. 4.
    Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6(4):328–340PubMedCrossRefGoogle Scholar
  5. 5.
    Ginger RS et al (2005) Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res 297(6):235–241PubMedCrossRefGoogle Scholar
  6. 6.
    Taieb A (1999) Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41(4):177–180PubMedCrossRefGoogle Scholar
  7. 7.
    Elias PM, Wood LC, Feingold KR (1999) Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10(3):119–126PubMedCrossRefGoogle Scholar
  8. 8.
    Rattner H (1943) Use of urea in hand creams. Arch Dermatol Syph 48:47–49CrossRefGoogle Scholar
  9. 9.
    Ashton H, Frenk E, Stevenson CJ (1971) Therapeutics XIII. Urea as a topical agent. Br J Dermatol 84:194–196PubMedCrossRefGoogle Scholar
  10. 10.
    Sweetman SC (ed) (2005) Martindale: the complete drug reference. Pharmaceutical Press, LondonGoogle Scholar
  11. 11.
    Rosten M (1970) The treatment of ichthyosis and hyperkeratotic conditions with urea. Australas J Dermatol 11:142–144PubMedCrossRefGoogle Scholar
  12. 12.
    Jacobi OK (1959) Moisture regulation in the skin. Drug Cosmet Ind 84:732–812Google Scholar
  13. 13.
    Kezic S et al (2011) Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 66(7):934–940PubMedCrossRefGoogle Scholar
  14. 14.
    Wellner K, Wohlrab W (1993) Quantitative evaluation of urea in stratum corneum of human skin. Arch Dermatol Res 285:239–240PubMedCrossRefGoogle Scholar
  15. 15.
    Swanbeck G (1968) A new treatment of ichthyosis and other hyperkeratotic conditions. Acta Derm Venereol Suppl (Stockh) 48:123–127Google Scholar
  16. 16.
    Grice K, Sattar H, Baker H (1973) Urea and retinoic acid in ichthyosis and their effect on transepidermal water loss and water holding capacity of stratum corneum. Acta Derm Venereol Suppl (Stockh) 54:114–118Google Scholar
  17. 17.
    CIR Expert Panel. (2005) Final report of the safety assessment of urea. Int J Toxicol 24(Suppl 3): 1–56Google Scholar
  18. 18.
    Hellgren L, Larsson K (1974) On the effect of urea on human epidermis. Dermatologica 149:89–93Google Scholar
  19. 19.
    Kunz D, Brassfield TS (1971) Hydration of macromolecules. II. Effects of urea on protein hydration. Arch Biochem Biophys 142:660–664CrossRefGoogle Scholar
  20. 20.
    Farber EM, South DA (1978) Urea ointment in the nonsurgical avulsion of nail dystrophies. Cutis 22:689–692PubMedGoogle Scholar
  21. 21.
    Lodén M, Bostrom P, Kneczke M (1995) Distribution and keratolytic effect of salicylic acid and urea in human skin. Skin Pharmacol 8(4):173–178PubMedCrossRefGoogle Scholar
  22. 22.
    Bentley MVLB et al (1997) The influence of lecithin and urea on the in vitro permeation of hydrocortisone acetate through skin from hairless mouse. Int J Pharm 146:255–262CrossRefGoogle Scholar
  23. 23.
    Costa-Balogh FO et al (2006) How small polar molecules protect membrane systems against osmotic stress: the urea-water-phospholipid system. J Phys Chem B 110(47):23845–23852PubMedCrossRefGoogle Scholar
  24. 24.
    Blair C (1976) The action of a urea-lactic acid ointment in ichthyosis. With particular reference to the thickness of the horny layer. Br J Dermatol 94:145–153PubMedCrossRefGoogle Scholar
  25. 25.
    Borelli C et al (2011) Cream or foam in pedal skin care: towards the ideal vehicle for urea used against dry skin. Int J Cosmet Sci 33(1):37–43PubMedCrossRefGoogle Scholar
  26. 26.
    Wohlrab W, Schiemann S (1976) Investigations on the mechanism of the activity of urea upon the epidermis [author’s transl]. Arch Dermatol Res 255(1):23–30PubMedCrossRefGoogle Scholar
  27. 27.
    Wohlrab W, Bohm W (1975) Reaction of epidermis after long-term action of urea. Dermatologica 151(3):149–157PubMedCrossRefGoogle Scholar
  28. 28.
    Hagemann I, Proksch E (1996) Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol Suppl (Stockh) 76:353–356Google Scholar
  29. 29.
    Sugiura H et al (2005) Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 152(1):146–149PubMedCrossRefGoogle Scholar
  30. 30.
    Hirao T et al (2003) Ratio of immature cornified envelopes does not correlate with parakeratosis in inflammatory skin disorders. Exp Dermatol 12(5):591–601PubMedCrossRefGoogle Scholar
  31. 31.
    Buraczewska I, 2 et al (2009) Long-term treatment with moisturizers affects keratinocyte differentiation and desquamation on the mRNA level. Arch Dermatol Res 301:175–181 [Epub 2008 Oct 11]PubMedCrossRefGoogle Scholar
  32. 32.
    Serup J (1992) A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol 177:34–43Google Scholar
  33. 33.
    Agner T (1992) An experimental study of irritant effects of urea in different vehicles. Acta Derm Venereol Suppl (Stockh) 177:44–46Google Scholar
  34. 34.
    Fredriksson T, Gip L (1975) Urea creams in the treatment of dry skin and hand dermatitis. Int J Dermatol 32:442–444CrossRefGoogle Scholar
  35. 35.
    Burkard G, Schmitt S (1992) Langzeitstudie Neurodermitis-Therapie mit harnstoffhaltigen externa. Hautarzt 43:13–17PubMedGoogle Scholar
  36. 36.
    Lodén M, Andersson A-C, Lindberg M (1999) The effect of two urea-containing creams on dry, eczematous skin in atopic patients. II. Adverse effects. J Dermatolog Treat 10:171–175CrossRefGoogle Scholar
  37. 37.
    Pigatto PD et al (1996) 10% urea cream (Laceran) for atopic dermatitis: a clinical and laboratory evaluation. J Dermatolog Treat 7:171–175CrossRefGoogle Scholar
  38. 38.
    Frithz A (1983) Investigation of Cortesal®, a hydrocortisone cream and its water-retaining cream base in the treatment of xerotic skin and dry eczemas. Curr Ther Res 33:930–935Google Scholar
  39. 39.
    Gabard B, Nook T, Muller KH (1991) Tolerance of the lesioned skin to dermatological formulations. J Appl Cosmetol 9:25–30Google Scholar
  40. 40.
    Frosch PJ, Kligman AM (1977) A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chem 28(28):197–209Google Scholar
  41. 41.
    De Groot AC et al (1988) Adverse effects of cosmetics and toiletries: a retrospective study in the general population. Int J Dermatol Sci 9:255–259Google Scholar
  42. 42.
    Horii Y et al (2011) Skin application of urea-containing cream affected cutaneous arterial sympathetic nerve activity, blood flow, and water evaporation. Skin Res Technol 17(1):75–81PubMedCrossRefGoogle Scholar
  43. 43.
    Taube KM (1992) Moisture retaining effect and tolerance of urea-containing Externa in neurodermatitis patients. Hautarzt 43(Suppl 11):30–32 [Article in German]PubMedGoogle Scholar
  44. 44.
    Baillie ATK et al (1973) General practitioner research group. Carbamide in hyperkeratosis. Report no 179. Practitioner 210:294–296Google Scholar
  45. 45.
    Bohnsack K et al (1997) Wirksamkeit auf das symptom ‘trockene haut’ und langzeitverträglichkeit von Laceran lotion 10% urea bei patienten mit atopischem ekzem. Z Hautkr 72:34–39Google Scholar
  46. 46.
    Andersson A-C, Lindberg M, Lodén M (1999) The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J Dermatolog Treat 10:165–169CrossRefGoogle Scholar
  47. 47.
    Bissonnette R et al (2010) A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol 9(1):16–21PubMedCrossRefGoogle Scholar
  48. 48.
    Lodén M, Andersson A-C, Lindberg M (1999) Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm®). Br J Dermatol 140:264–267PubMedCrossRefGoogle Scholar
  49. 49.
    Lodén M et al (2001) Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 7(4):209–213PubMedCrossRefGoogle Scholar
  50. 50.
    Sasaki Y, Tadaki T, Tagami H (1989) The effects of a topical application of urea cream on the function of pathological stratum corneum. Acta Dermatol Kyoto 84(1989):581Google Scholar
  51. 51.
    Pope FM et al (1972) Out-patient treatment of ichthyosis: a double-blind trial of ointments. Br J Dermatol 86:291–296PubMedCrossRefGoogle Scholar
  52. 52.
    Kuster W et al (1998) Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 196:217–222PubMedCrossRefGoogle Scholar
  53. 53.
    Schölermann A et al (1999) Wirksamkeit und verträglichkeit von Eucerin salbe 10% urea bei xerotischer altershau.: Ergebnisse einer vehikel-kontrollierten klinischen doppelblindstudie. Z Hautkr 74:557–562Google Scholar
  54. 54.
    Schölermann A et al (1998) Efficacy and safety of Eucerin 10% urea lotion in the treatment of symptoms of aged skin. J Dermatolog Treat 9:175–179CrossRefGoogle Scholar
  55. 55.
    Kuzmina N, Hagstromer L, Emtestam L (2002) Urea and sodium chloride in moisturisers for skin of the elderly – a comparative, double-blind, randomised study. Skin Pharmacol Appl Skin Physiol 15(3):166–174PubMedCrossRefGoogle Scholar
  56. 56.
    Ademola J et al (2002) Clinical evaluation of 40% urea and 12% ammonium lactate in the treatment of xerosis. Am J Clin Dermatol 3:217–222PubMedCrossRefGoogle Scholar
  57. 57.
    Pham HT et al (2002) A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage 48(5):30–36PubMedGoogle Scholar
  58. 58.
    Sadick NS et al (2010) Efficacy and safety of a new topical keratolytic treatment for localized hyperkeratosis in adults. J Drugs Dermatol 9(12):1512–1517PubMedGoogle Scholar
  59. 59.
    Goldstein JA, Gurge RM (2008) Treatment of hyperkeratosis with Kerafoam emollient foam (30% urea) to assess effectiveness and safety within a clinical setting: a case study report. J Drugs Dermatol 7(2):159–162PubMedGoogle Scholar
  60. 60.
    Pardo Masferrer J et al (2010) Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Clin Transl Oncol 12(1):43–48PubMedCrossRefGoogle Scholar
  61. 61.
    Wolf SL et al (2010) Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. J Clin Oncol 28(35):5182–5187PubMedCrossRefGoogle Scholar
  62. 62.
    Demerjian M et al (2009) Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Exp Dermatol 18(7):643–649PubMedCrossRefGoogle Scholar
  63. 63.
    Jensen JM et al (2009) Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 124(3 Suppl 2):R19–R28PubMedCrossRefGoogle Scholar
  64. 64.
    Kao JS et al (2003) Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 120(3):456–464PubMedCrossRefGoogle Scholar
  65. 65.
    Kolbe L et al (2001) Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 7(2):73–77PubMedCrossRefGoogle Scholar
  66. 66.
    Loden M et al (2011) The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial. J Eur Acad Dermatol Venereol. doi: 10.1111/j.1468-3083.2011.04128.x [Epub ahead of print]
  67. 67.
    Hindson MTC (1971) Urea in the topical treatment of atopic eczema. Arch Dermatol 104:284–285PubMedCrossRefGoogle Scholar
  68. 68.
    Wohlrab W (1990) The influence of urea on the penetration kinetics of vitamin-A-acid into human skin. Z Hautkr 65:803–805PubMedGoogle Scholar
  69. 69.
    Wohlrab W (1984) The influence of urea on the penetration kinetics of topically applied corticosteroids. Acta Derm Venereol 64(3):233–238PubMedGoogle Scholar
  70. 70.
    Wohlrab W (1989) Significance of urea in external therapy. Hautarzt 40(Suppl 9):35–41PubMedCrossRefGoogle Scholar
  71. 71.
    Beastall J et al (1986) The influence of urea on percutaneous absorption. Pharm Res 3:294–297CrossRefGoogle Scholar
  72. 72.
    Kim CK et al (1993) Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm 99:109–118CrossRefGoogle Scholar
  73. 73.
    Allenby AC et al (1969) Mechanism of action of accelerants on skin penetration. Br J Dermatol 81(suppl 4):47–55CrossRefGoogle Scholar
  74. 74.
    Wahlberg JE, Swanbeck G (1973) The effect of urea and lactic acid on the percutaneous absorption of hydrocortisone. Acta Derm Venereol 53(3):207–210PubMedGoogle Scholar
  75. 75.
    Lippold BC, Hackemuller D (1990) The influence of skin moisturizers on drug penetration in vivo. Int J Pharm 61:205–211CrossRefGoogle Scholar
  76. 76.
    Stuttgen G (1989) Penetrationsförderung lokal applizierter Wirkstoffe durch Harnstoff. Hautarzt 40(Suppl 9):27–31PubMedCrossRefGoogle Scholar
  77. 77.
    McCallion R, Po ALW (1994) Modelling transepidermal water loss under steady-state and non-steady-state relative humidities. Int J Pharm 105:103–112CrossRefGoogle Scholar
  78. 78.
    Duval D et al (2002) Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res Technol 8:1–5CrossRefGoogle Scholar
  79. 79.
    Kuzmina N et al (2004) Effects of pre-treatment an emollient containing urea on nickel allergic skin reactions. Acta Derm Venereol 84:1–4Google Scholar
  80. 80.
    Lodén M (1996) Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 288(2):103–107PubMedCrossRefGoogle Scholar
  81. 81.
    Lodén M (1997) Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 36(5):256–260PubMedCrossRefGoogle Scholar
  82. 82.
    Buraczewska I et al (2007) Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 156(3):492–498PubMedCrossRefGoogle Scholar
  83. 83.
    Lodén M et al (2004) The influence of urea treatment on skin susceptibility to surfactant-induced irritation: a placebo-controlled and randomized study. Exogen Dermatol 3:1–6CrossRefGoogle Scholar
  84. 84.
    Hagströmer L, Nyrén M, Emtestam L (2001) Do urea and sodium chloride together increase the efficacy of moisturizers for atopic dermatitis skin. A comparative, double-blind and randomised study. Skin Pharmacol Appl Skin Physiol 14:27–33PubMedCrossRefGoogle Scholar
  85. 85.
    Wirén K et al. (2009) Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis. A prospective and randomized controlled clinical trial. JEADV, 23:1267–1272.Google Scholar
  86. 86.
    Hjalte F, Asseburg C, Tennvall GR (2010) Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden – with model applications for Denmark, Norway and Finland. J Eur Acad Dermatol Venereol 24(4):474–480PubMedCrossRefGoogle Scholar
  87. 87.
    Loden M et al (2010) Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 90(6):602–606PubMedCrossRefGoogle Scholar
  88. 88.
    Lodén M (2003) Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 4(11):771–788PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Eviderm Institute AB, Research and DevelopmentSolnaSweden

Personalised recommendations